Viridian Therapeutics, Inc.\DE (VRDN) FCF Margin (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) reported FCF Margin of -37545.77% for Q2 2026, up 63007.56 percentage points from -100553.33% a year earlier and up 47331.53 percentage points from the prior quarter.
Viridian Therapeutics, Inc.\DE (VRDN) FCF Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viridian Therapeutics, Inc.\DE's FCF Margin came in at -471.04%, up 101036.83 percentage points year-over-year; for FY2025, it came in at -390.81%, up 76705.22 percentage points from FY2024.
- FCF Margin has a five-year change of +2449.28 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at -77096.03% in FY2024 (-18157.17 pp), -58938.85% in FY2023 (-53598.28 pp), -5340.58% in FY2022 (-3487.08 pp) and -1853.49% in FY2021 (+986.60 pp).
- Five-year quarterly FCF Margin spans a low of -128804.17% in Q1 2025 and a high of -120.08% in Q3 2025.
- Year over year, FCF Margin has now increased in each of the last four quarters, with an average year-over-year change of +11718.97 percentage points over the last eight quarters.
- The high point for year-over-year FCF Margin in five years was Q4 2025 (a gain of 83831.06 percentage points); the low point was Q1 2025 (a drop of 65994.44 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -84877.30% (Q1 2026), -18177.27% (Q4 2025) and -120.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | -37,545.77% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37,545.77% |
| Mar 31, 2026 | -84,877.30% |
| Dec 31, 2025 | -18,177.27% |
| Sep 30, 2025 | -120.08% |
| Jun 30, 2025 | -100,553.33% |
| Mar 31, 2025 | -128,804.17% |
| Dec 31, 2024 | -102,008.33% |
| Sep 30, 2024 | -79,068.60% |
| Jun 30, 2024 | -64,113.89% |
| Mar 31, 2024 | -62,809.72% |
| Dec 31, 2023 | -52,844.44% |
| Sep 30, 2023 | -54,704.17% |
| Jun 30, 2023 | -63,256.94% |
| Mar 31, 2023 | -63,355.10% |
| Dec 31, 2022 | -32,640.95% |
| Sep 30, 2022 | -1,737.49% |
| Jun 30, 2022 | -7,178.91% |
| Mar 31, 2022 | -9,824.54% |
| Dec 31, 2021 | -7,765.89% |
| Sep 30, 2021 | -5,798.56% |
Viridian Therapeutics, Inc.\DE FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();